Hemp called ‘golden opportunity’ for Peru, but progress is lacking
Cannabis advocates in Peru say establishing a hemp program – now non-existent – is key to better aligning the country with international Sustainable Development Goals…
Medical
Stakeholders in Malaysia decry slow development of hemp program
Malaysian cannabis stakeholders have welcomed policy clarifications that appear to open the market for medical marijuana, but say the government should do more to advance…
Proposed Virginia bill would let hemp processors get into marijuana business
Hemp processors in Virginia could sell recreational marijuana and get a one-year jump on the market if they pay the state a one-time fee of…
Law in Costa Rica awaits decision by president; will he sign?
Costa Rica’s president said he is studying a bill that would legalize medical marijuana and industrial hemp, giving no clear indication if he will sign…
FDA approves trial for CBD-based drug to treat opioid addiction
The U.S. Food & Drug Administration (FDA) said a CBD-based treatment for opioid use disorder can be used in clinical trials, Ananda Scientific Inc., the…
Two hemp compounds show promise in fighting covid-19 virus
Two compounds present in industrial hemp show the ability to prevent the virus that causes covid-19 from entering human cells, according to researchers in Oregon….
Pfizer to pay $6.7 billion for developer of cannabinoid medicines
Pharmaceutical giant Pfizer said it plans to buy San Diego-based Arena Pharmaceuticals, Inc., which is researching and developing cannabinoid-based medicines for patients who suffer gastrointestinal…
NZ company to make CBD
New Zealand pharma company Rua Bioscience said it has received a Good Manufacturing Practice (GMP) certification from Medsafe, the medicines and medical devices safety authority…
German, Swiss, Canadian companies get licenses in Zimbabwe
Investors from Germany, Switzerland and Canada are among those who have received cultivation and processing licenses under Zimbabwe’s cannabis program. A total of 57 licenses…
Epydiolex approved to treat rare genetic disorder in UK
CBD-based Epydiolex has received approval in the UK as an adjunctive treatment for seizures associated with tuberous sclerosis complex (TSC), the drug’s maker, GW Pharmaceuticals, announced….
